Stock Movers

On this episode of Stock Movers:
- Onsemi (ON) shares ended the week lower following news the US chipmaker has agreed to buy Synaptics Inc., a firm that specializes in semiconductors for smart devices.
- Bio-Techne (TECH) shares ended the week higher after Merck agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade.
- Oracle (ORCL) stock plummeted this week as concerns mount over the company's debt-load and following the news reported by the New York Times that OpenAI could delay its IPO until next year.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Goldman Sachs (GS) slide after the New York Times reported that bankers advising OpenAI cautioned that volatility in tech stocks could dent enthusiasm for an offering.
- Onsemi (ON) shares slide following news the US chipmaker has agreed to buy Synaptics Inc., a firm that specializes in semiconductors for smart devices.
- Darden Restaurants (DRI) dips slightly after the restaurant chain operator reported worse-than-expected sales performance for Olive Garden, while the LongHorn’s unit topped the Street view.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Strategy (MSTR) shares are mixed. On Friday, Billionaire Michael Saylor on Friday defended Strategy’s approach to Bitcoin.
- Netflix (NFLX) shares rise. Investors weigh the company’s push into live sports despite a thinning slate of mega-hit series.
- Moderna (MRNA) shares rise. Piper Sandler raised the firm's price target on Moderna to $77 from $69 and keeps an Overweight rating on the shares.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
Synaptics (SYNA) shares rise. Onsemi has agreed to buy Synaptics Inc. in an all-stock deal that values the company at about $6.2 billion. The transaction has a total enterprise value including debt of roughly $7 billion and is expected to close in mid-2027, subject to approvals.
Lumentum (LITE) shares fall. U.S. optical communication stocks dropped. This comes as Semiconductor stocks are broadly lower.
Acadia Pharma (ACAD) shares climb as much as 12%, the most intraday since May 2025, after the drugmaker said the European Medicines Agency’s CHMP issued a positive opinion for its drug to treat symptoms of Rett syndrome and recommended granting a marketing authorization.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- US chipmaker Onsemi (ON) has agreed to buy Synaptics (SYNA), a firm that specializes in semiconductors for smart devices, in an all-stock deal that values the company at about $6.2 billion.
- Rocket Lab (RKLB) shares rise as the space firm says NASA selected it to provide three Electron launches for two missions, PolSIR and TSIS-2, from early 2027.
- Microsoft (MSFT) shares are down, with the software giant extending a recent selloff. The stock is down more than 20% this month, putting it on track for its biggest one-month percentage drop since December 2000
See omnystudio.com/listener for privacy information.